Prevalence and Trends in Antimicrobial Susceptibility Patterns of Multi-Drug-Resistance Non-Typhoidal Salmonella in Central Thailand, 2012–2019

References

• Drug-resistant Nontyphoidal Salmonella; 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/nt-salmonella-508.pdf. Accessed June 30, 2019.
   Google Scholar
• Medalla F, Hoekstra RM, Whichard JM, et al. Increase in resistance to ceftriaxone and nonsusceptibility to ciprofloxacin and decrease in multidrug resistance among salmonella strains, United States, 1996–2009. Foodborne Pathog Dis. 2013;10(4):302–309. doi:10.1089/fpd.2012.1336
   PubMed Web of Science ®Google Scholar
• Rabsch W, Tschäpe H, Bäumler AJ. Non-typhoidal salmonellosis: emerging problems. Microbes Infect. 2001;3(3):237–247. doi:10.1016/S1286-4579(01)01375-2
   Web of Science ®Google Scholar
• Zhang J, Jin H, Hu J, et al. Serovars and antimicrobial resistance of non-typhoidal Salmonella from human patients in Shanghai, China, 2006–2010. Epidemiol Infect. 2014;142(4):826–832. doi:10.1017/S0950268813001659
   Web of Science ®Google Scholar
• Stanaway JD, Parisi A, Sarkar K, Collaborators GBDN-TSID. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the global burden of disease study 2017. Lancet Infect Dis. 2019;19(12):1312–1324. doi:10.1016/S1473-3099(19)30418-9
   PubMed Web of Science ®Google Scholar
• Chen CY, Hsieh PH, Chang CY, et al. Molecular epidemiology of the emerging ceftriaxone resistant non-typhoidal Salmonella in southern Taiwan. J Microbiol Immunol Infect. 2019;52(2):289–296. doi:10.1016/j.jmii.2018.08.007
   Google Scholar
• Li WC, Huang FY, Liu CP, et al. Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 beta-lactamases. J Clin Microbiol. 2005;43(7):3237–3243. doi:10.1128/JCM.43.7.3237-3243.2005
   Web of Science ®Google Scholar
• Jain P, Chowdhury G, Samajpati S, et al. Characterization of non-typhoidal Salmonella isolates from children with acute gastroenteritis, Kolkata, India, during 2000–2016. Braz J Microbiol. 2020;51(2):613–627. doi:10.1007/s42770-019-00213-z
   Web of Science ®Google Scholar
• Lee K, Yong D, Yum JH, Kim HH, Chong Y. Diversity of TEM-52 extended-spectrum beta-lactamase-producing non-typhoidal Salmonella isolates in Korea. J Antimicrob Chemother. 2003;52(3):493–496. doi:10.1093/jac/dkg385
   Web of Science ®Google Scholar
• Narasanna R, Chavadi M, Chandrakanth K. Prevalence of multidrug-resistant Salmonella typhi in typhoid patients and detection of blaCTX-M2 and blaCTX-M9 genes in cefetoxime-mediated extended spectrum β-lactamase-producing Salmonella typhi isolates. Biomed Res. 2018;29(14):3015–3021. doi:10.4066/biomedicalresearch.29-18-794
   Google Scholar
• National Antimicrobial Resistant Surveillance Center T. The situation of drug resistance 2000–2020 (6M); 2020.
   Google Scholar
• Chang YJ, Chen YC, Chen NW, et al. Changing antimicrobial resistance and epidemiology of non-typhoidal Salmonella infection in Taiwanese Children. Front Microbiol. 2021;12:648008. doi:10.3389/fmicb.2021.648008
   Web of Science ®Google Scholar
• Woh PY, Yeung MPS, Goggins WB, et al. Genomic epidemiology of multidrug-resistant nontyphoidal Salmonella in young children hospitalized for gastroenteritis. Microbiol Spectrum. 2021;9(1):e0024821. doi:10.1128/Spectrum.00248-21
   Web of Science ®Google Scholar
• Duong VT, The HC, Nhu TDH, et al. Genomic serotyping, clinical manifestations, and antimicrobial resistance of nontyphoidal salmonella gastroenteritis in hospitalized children in Ho Chi Minh City, Vietnam. J Clin Microbiol. 2020;58(12):e01465–20. doi:10.1128/JCM.01465-20
   Web of Science ®Google Scholar
• Situation Domestic Travellers by Province: 2010 – 2019. Tourism and sport statistics. Available from:http://statbbi.nso.go.th/staticreport/page/sector/en/17.aspx. Accessed February 6, 2020.
   Google Scholar
• WHO: 2014–2016 ICD-10-CM Diagnosis Code A02.0-02.9 Salmonella infection. Available from: https://www.icd10data.com/ICD10CM/Codes/A00-B99/A00-A09/A02-/A02.9. Accessed June 30, 2019.
   Google Scholar
• Grimont PA, Weill FX. Antigenic formulae of the Salmonella Serovars. WHO Collaborating Centre for Reference and Research on Salmonella; 2007.
   Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Bureau of Laboratory Quality S. History and Authority. Available from: http://blqs.dmsc.moph.go.th/en/page-view/22. Accessed June 30, 2019.
   Google Scholar
• Magiorakos A, Srinivasan RB, Carey Y, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Whistler T, Sapchookul P, McCormick DW, et al. Epidemiology and antimicrobial resistance of invasive non-typhoidal Salmonellosis in rural Thailand from 2006–2014. PLoS Negl Trop Dis. 2018;12(8):e0006718–e0006718. doi:10.1371/journal.pntd.0006718
   Web of Science ®Google Scholar
• Kariuki S, Mbae C, Onsare R, et al. Multidrug-resistant nontyphoidal Salmonella hotspots as targets for vaccine use in management of infections in endemic settings. Clin Infect Dis. 2019;68(Suppl 1):S10–S15. doi:10.1093/cid/ciy898
   Web of Science ®Google Scholar
• Srijan A, Lurchachaiwong W, Wongstitwilairoong B, Bodhidatta L, Mason C, Swierczewski B. Prevalence and antimicrobial resistance of non-typhoid Salmonella in military personnel, 1988–2013. Asian Pac J Trop Med. 2018;11:387–392. doi:10.4103/1995-7645.234767
   Web of Science ®Google Scholar
• Tack B, Marie-France P, Barbé B, et al. Non-typhoidal Salmonella bloodstream infections in Kisantu, DR Congo: emergence of O5-negative Salmonella Typhimurium and extensive drug resistance. PLoS Negl Trop Dis. 2020;14(4):e0008121. doi:10.1371/journal.pntd.0008121
   Web of Science ®Google Scholar
• Miriam W, Nathan K. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis. 2005;18(6):513–521. doi:10.1097/01.qco.0000186851.33844.b2
   Web of Science ®Google Scholar
• Gunell M, Webber MA, Kotilainen P, et al. Mechanisms of resistance in nontyphoidal strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother. 2009;53(9):3832–3836. doi:10.1128/AAC.00121-09
   Web of Science ®Google Scholar
• Kulwichit W, Chatsuwan T, Unhasuta C, Pulsrikarn C, Bangtrakulnonth A, Chongthaleong A. Drug-resistant nontyphoidal Salmonella bacteremia, Thailand. Emerg Infect Dis. 2007;13(3):501–502. doi:10.3201/eid1303.061059
   Web of Science ®Google Scholar
• Liang Z, Ke B, Deng X, et al. Serotypes, seasonal trends, and antibiotic resistance of non-typhoidal Salmonella from human patients in Guangdong Province, China, 2009–2012. BMC Infect Dis. 2015;15:53. doi:10.1186/s12879-015-0784-4
   PubMed Web of Science ®Google Scholar
• Lee H-Y, Su L-H, Tsai M-H, et al. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid clinical isolates in Asia. Antimicrob Agents Chemother. 2009;53(6):2696–2699. doi:10.1128/AAC.01297-08
   Web of Science ®Google Scholar
• Wen SCH, Best E, Nourse C. Non-typhoidal Salmonella infections in children: review of literature and recommendations for management. J Paediatr Child Health. 2018;53(10):936–941. doi:10.1111/jpc.13585
   Web of Science ®Google Scholar
• Price EH, de Louvois J, Workman MR. Antibiotics for Salmonella meningitis in children. J Paediatr Child Health. 2017;53(10):936–941.
   Google Scholar
• Javier F, Beatriz G, Rosario RM. Resistance to carbapenems in non-typhoidal Salmonella enterica serovars from humans, animals and food. Vet Sci. 2018;5(2):40. doi:10.3390/vetsci5020040
   Web of Science ®Google Scholar
• Day MR, Meunier D, Doumith M, de Pinna E, Woodford N, Hopkins KL. Carbapenemase-producing Salmonella enterica isolates in the UK. Antimicrob Agents Chemother. 2015;70(7):2165–2167. doi:10.1093/jac/dkv075
   Web of Science ®Google Scholar
• Changab YJ, Chena MC, Feng Y, et al. Highly antimicrobial-resistant Nontyphoidal Salmonella from retail meats and clinical impact in children, Taiwan. Pediatr Neonatol. 2020;61(4):432–438. doi:10.1016/j.pedneo.2020.03.017
   Web of Science ®Google Scholar
• Varma JK, Mølbak K, Barrett TJ, et al. Antimicrobial‐resistant nontyphoidal salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis. 2005;191(4):554–561. doi:10.1086/427263
   PubMed Web of Science ®Google Scholar
• Fuche FJ, Sow O, Simon R, Tennant SM, Salmonella Serogroup C, Papasian CJ. Current status of vaccines and why they are needed. Clin Vaccine Immunol. 2016;23(9):737–745. doi:10.1128/CVI.00243-16
   PubMedGoogle Scholar
• Tack B, Vanaenrode J, Verbakel JY, Toelen J, Jacobs J. Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment. BMC Med. 2020;18(1):212. doi:10.1186/s12916-020-01652-4
   Web of Science ®Google Scholar
• Liang B, Xie Y, He S, et al. Prevalence, serotypes, and drug resistance of nontyphoidal Salmonella among pediatric patients in a tertiary hospital in Guangzhou, China, 2014–2016. J Infect Public Health. 2019;12(2):252–257. doi:10.1016/j.jiph.2018.10.012
   Web of Science ®Google Scholar